Polpharma Biologics Rebrands As New Warsaw Site Is Validated
First Production Run Expected In Mid-2021
As it gears up to begin production at its new clinical and commercial manufacturing site in Warsaw, Polpharma Biologics has announced a new logo and corporate message to mark a year of “significant growth.”